Product Name: Human CD19 Antibody (Inebilizumab, Research Use)
Catalog Number: NBR-0007
Target Name: CD19
Trade Name: Inebilizumab
Antibody Drug Description: Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD19
Synonyms: N/A
Target Description: Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens.
Ensembl: ENSG00000177455
Uniprot: P15391